The outbreak of pneumonia-like respiratory disorder at China and its rapid transmission
world-wide resulted in public health emergency, which brought lineage B betacoronaviridae …

Acute respiratory infection is the third most frequent cause of mortality worldwide, causing
over 4.25 million deaths annually. Although most diagnosed acute respiratory infections are …

Since the recent outbreak of COVID-19, there have been intense efforts to understand viral
pathogenesis and host immune response to combat SARS-CoV-2. It has become evident …

At present, global vaccination for the SARS-CoV2 virus 2019 (COVID-19) is 95% effective.
Generally, viral infections are arduous to cure due to the mutating nature of viral genomes …

Introduction SARS-CoV-2 variants are defined by specific genome-wide mutations
compared to the Wuhan genome. However, non-clade-defining mutations may also impact …

Introduction: SARS-CoV-2 belongs to the coronavirus family, a large family of viruses
infecting avian and mammalian hosts. Accumulated mutations over time in the genome of …

Background: Different positive end-expiratory pressure (PEEP) strategies are available for
subjects with coronavirus disease 2019 (COVID-19)–induced acute respiratory distress …

Proteomics has been found to be a helpful tool in understanding COVID-19 disease. It has
provided important insights into the complex interactions between the SARS-CoV-2 virus …

Novel technologies and state of the art platforms developed and launched over the last two
decades such as microarrays, next-generation sequencing, and droplet PCR have provided …

COVID-19 pandemic has affected the world in all its dimensions. With herd immunity being a
distant and non-practical possibility, vaccination remains most tractable approach to reduce …